MODE Trademark

Trademark Overview


On Tuesday, August 1, 2023, a trademark application was filed for MODE with the United States Patent and Trademark Office. The USPTO has given the MODE trademark a serial number of 98112146. The federal status of this trademark filing is FIRST EXTENSION - GRANTED as of Tuesday, April 2, 2024. This trademark is owned by Biohaven Therapeutics Ltd.. The MODE trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical products, namely, multifunctional molecules that bind to extracellular circulating disease-causing proteins and other biomolecules and target them for lysosomal degradation, for use in the treatment of autoimmune disorders, inflammatory diseases and conditions, metabolic disorders, allergies, cancers, infectious diseases, and neurological disorders

Discovery in the nature of pharmaceutical research, development, engineering and testing, namely, for multifunctional molecules that bind to extracellular circulating disease-causing proteins and other biomolecules and target them for lysosomal degradation, for use in the treatment of autoimmune disorders, inflammatory diseases and conditions, metabolic disorders, allergies, cancers, infectious diseases, and neurological disorders
mode

General Information


Serial Number98112146
Word MarkMODE
Filing DateTuesday, August 1, 2023
Status730 - FIRST EXTENSION - GRANTED
Status DateTuesday, April 2, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 31, 2023

Trademark Statements


Goods and ServicesPharmaceutical products, namely, multifunctional molecules that bind to extracellular circulating disease-causing proteins and other biomolecules and target them for lysosomal degradation, for use in the treatment of autoimmune disorders, inflammatory diseases and conditions, metabolic disorders, allergies, cancers, infectious diseases, and neurological disorders
Goods and ServicesDiscovery in the nature of pharmaceutical research, development, engineering and testing, namely, for multifunctional molecules that bind to extracellular circulating disease-causing proteins and other biomolecules and target them for lysosomal degradation, for use in the treatment of autoimmune disorders, inflammatory diseases and conditions, metabolic disorders, allergies, cancers, infectious diseases, and neurological disorders

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, August 30, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, August 30, 2023
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameBiohaven Therapeutics Ltd.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressRoad Town, Tortola VG1110
VG

Party NameBiohaven Therapeutics Ltd.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressRoad Town, Tortola VG1110
VG

Trademark Events


Event DateEvent Description
Wednesday, April 3, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, April 2, 2024SOU EXTENSION 1 GRANTED
Tuesday, April 2, 2024SOU EXTENSION 1 FILED
Tuesday, April 2, 2024SOU TEAS EXTENSION RECEIVED
Friday, January 5, 2024ASSIGNED TO EXAMINER
Tuesday, December 26, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, November 29, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, November 29, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, November 29, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, October 31, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 31, 2023PUBLISHED FOR OPPOSITION
Wednesday, October 11, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, September 25, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, September 23, 2023ASSIGNED TO EXAMINER
Wednesday, August 30, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, August 4, 2023NEW APPLICATION ENTERED